Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2 V1 pseudogene 4 (UBE2V1P4)

Target
UBE2V1P4
Molecular classification
Other
01

Overview

UBE2V1P4 is a **pseudogene** of the UBE2V1 gene, catalogued as "UBE2V1 Pseudogene 4." Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they do not produce a functional protein. UBE2V1P4 does not encode an active enzyme or receptor and has no known biological function, disease association, or pharmacological relevance. It is not considered a therapeutic target[4]. **Key context:** - UBE2V1P4, by definition, does not produce a functional protein and is not a drug target or active biomolecule[4]. - The functional gene in this family, UBE2V1, encodes a ubiquitin-conjugating enzyme variant involved in ubiquitination and cell signaling[1][3], but the pseudogene (UBE2V1P4) does not share these functions[4]. - No evidence is available for UBE2V1P4's involvement in disease, drug interaction, biomarker applications, or safety concerns due to its lack of protein product or biological activity[4].

Other names
ubiquitin conjugating enzyme E2 variant 1 pseudogene 4ubiquitin-conjugating enzyme E2 variant 1 pseudogene 4ubiquitin-conjugating enzyme E2 variant 1 pseudogene

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2 V1 pseudogene 4 (UBE2V1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 V1 pseudogene 4 (UBE2V1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call